{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T18:24:50Z","timestamp":1781979890460,"version":"3.54.5"},"reference-count":46,"publisher":"Society of Nuclear Medicine","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med.\n                Technol."],"accepted":{"date-parts":[[2025,10,21]]},"published-print":{"date-parts":[[2025,12]]},"DOI":"10.2967\/jnmt.125.271082","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T13:40:17Z","timestamp":1764855617000},"page":"132S-140S","source":"Crossref","is-referenced-by-count":2,"title":["Tumor Differentiation and the Role of Nuclear Medicine Scintigraphy and Therapy"],"prefix":"10.2967","volume":"53","author":[{"given":"Julie Dawn","family":"Bolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"2025121109350928000_53.Supplement_1.132S.1","unstructured":"Tumor grade. National Cancer Institute website. https:\/\/www.cancer.gov\/about-cancer\/diagnosis-staging\/diagnosis\/tumor-grade. Updated August 1, 2022. Accessed October 14, 2025."},{"key":"2025121109350928000_53.Supplement_1.132S.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2015.12.001"},{"key":"2025121109350928000_53.Supplement_1.132S.3","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e3182393599"},{"key":"2025121109350928000_53.Supplement_1.132S.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267982"},{"key":"2025121109350928000_53.Supplement_1.132S.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.069765"},{"key":"2025121109350928000_53.Supplement_1.132S.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.144386"},{"key":"2025121109350928000_53.Supplement_1.132S.7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2021.01.008","article-title":"Consensus on molecular imaging and theranostics in neuroendocrine neoplasms","volume":"146","author":"Ambrosini","year":"2021","journal-title":"Eur J Cancer."},{"key":"2025121109350928000_53.Supplement_1.132S.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.241414"},{"key":"2025121109350928000_53.Supplement_1.132S.9","doi-asserted-by":"crossref","first-page":"1103354","DOI":"10.3389\/fphys.2023.1103354","article-title":"Imaging glucose metabolism to reveal tumor progression","volume":"14","author":"Meng","year":"2023","journal-title":"Front Physiol."},{"key":"2025121109350928000_53.Supplement_1.132S.10","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0020"},{"key":"2025121109350928000_53.Supplement_1.132S.11","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00586-x"},{"key":"2025121109350928000_53.Supplement_1.132S.12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejso.2017.05.002","article-title":"Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management","volume":"44","author":"Xu","year":"2018","journal-title":"Eur J Surg Oncol."},{"key":"2025121109350928000_53.Supplement_1.132S.13","unstructured":"Pusztaszeri M . Differentiated high-grade thyroid carcinoma (HGDTC). https:\/\/www.pathologyoutlines.com\/topic\/thyroiddifferentiatedhighgrade.html. Updated August 12, 2025. Accessed October 14, 2025."},{"key":"2025121109350928000_53.Supplement_1.132S.14","unstructured":"Lee K Anastasopoulou C Sdran C Cassaro S . Thyroid cancer. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK536943\/. Updated May 1, 2023. Accessed October 14, 2025."},{"key":"2025121109350928000_53.Supplement_1.132S.15","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.3390\/curroncol31060252","article-title":"A comprehensive review and insights into the new entity of differentiated high-grade thyroid carcinoma","volume":"31","author":"Harahap","year":"2024","journal-title":"Curr Oncol."},{"key":"2025121109350928000_53.Supplement_1.132S.16","unstructured":"Tuttle RM . Papillary thyroid cancer: clinical features and prognosis. https:\/\/www.uptodate.com\/contents\/papillary-thyroid-cancer-clinical-features-and-prognosis. Updated March 6, 2025. Accessed October 14, 2025."},{"key":"2025121109350928000_53.Supplement_1.132S.17","unstructured":"Palot Manzil FF Kaur H . Radioactive iodine therapy for thyroid malignancies. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK580567\/. Updated November 25, 2024. Accessed October 14, 2025."},{"key":"2025121109350928000_53.Supplement_1.132S.18","doi-asserted-by":"crossref","first-page":"e230099","DOI":"10.1530\/ETJ-23-0099","article-title":"Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up","volume":"12","author":"Nilsson","year":"2023","journal-title":"Eur Thyroid J."},{"key":"2025121109350928000_53.Supplement_1.132S.19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40644-024-00791-8","article-title":"Role of [18F]FDG PET\/CT in the management of follicular cell-derived thyroid carcinoma","volume":"24","author":"Zajkowska","year":"2024","journal-title":"Cancer Imaging."},{"key":"2025121109350928000_53.Supplement_1.132S.20","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0944"},{"key":"2025121109350928000_53.Supplement_1.132S.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209288"},{"key":"2025121109350928000_53.Supplement_1.132S.22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2915"},{"key":"2025121109350928000_53.Supplement_1.132S.23","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1210\/jc.2018-01478","article-title":"Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers","volume":"104","author":"Dunn","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2025121109350928000_53.Supplement_1.132S.24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.6785"},{"key":"2025121109350928000_53.Supplement_1.132S.25","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1210\/jc.2018-00612","article-title":"Targeted therapy in advanced thyroid cancer to resensitize tumors to radioactive iodine","volume":"103","author":"Jaber","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"2025121109350928000_53.Supplement_1.132S.26","doi-asserted-by":"publisher","DOI":"10.1111\/his.13975"},{"key":"2025121109350928000_53.Supplement_1.132S.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0110-y"},{"key":"2025121109350928000_53.Supplement_1.132S.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.244798"},{"key":"2025121109350928000_53.Supplement_1.132S.29","unstructured":"Menon G Karanchi H . Gastrointestinal neuroendocrine tumors. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448101\/. Updated May 23, 2025. Accessed October 14, 2025."},{"key":"2025121109350928000_53.Supplement_1.132S.30","unstructured":"Yang Z . Neuroendocrine neoplasms of the gastrointestinal tract and pancreas: pathology, classification, and grading. https:\/\/www.uptodate.com\/contents\/neuroendocrine-neoplasms-of-the-gastrointestinal-tract-and-pancreas-pathology-classification-and-grading. Updated May 19, 2025. Accessed October 14, 2025."},{"key":"2025121109350928000_53.Supplement_1.132S.31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.7150\/thno.19588","article-title":"The NETPET score: combining FDG and somatostatin receptor imaging for optimal management of patients with metastatic well-differentiated neuroendocrine tumors","volume":"7","author":"Hindi\u00e9","year":"2017","journal-title":"Theranostics."},{"key":"2025121109350928000_53.Supplement_1.132S.32","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.7150\/thno.18068","article-title":"Dual somatostatin receptor\/FDG PET\/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance","volume":"7","author":"Chan","year":"2017","journal-title":"Theranostics."},{"key":"2025121109350928000_53.Supplement_1.132S.33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41416-022-02061-5","article-title":"Dual [68Ga]DOTATATE and [18F]FDG PET\/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score","volume":"128","author":"Chan","year":"2023","journal-title":"Br J Cancer."},{"key":"2025121109350928000_53.Supplement_1.132S.34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40644-022-00465-3","article-title":"Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms","volume":"22","author":"Iravani","year":"2022","journal-title":"Cancer Imaging."},{"key":"2025121109350928000_53.Supplement_1.132S.35","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265706"},{"key":"2025121109350928000_53.Supplement_1.132S.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05501-1"},{"key":"2025121109350928000_53.Supplement_1.132S.37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1053\/j.semnuclmed.2025.06.006","article-title":"PSMA-targeted positron emission tomography imaging in solid tumors other than prostate carcinoma: an update","volume":"55","author":"Nyakale","year":"2025","journal-title":"Semin Nucl Med."},{"key":"2025121109350928000_53.Supplement_1.132S.38","first-page":"117","article-title":"The evolving role of prostate-specific membrane antigen\u2013based diagnostics and therapeutics in prostate cancer","volume":"39","author":"Dorff","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book."},{"key":"2025121109350928000_53.Supplement_1.132S.39","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/diagnostics14232751","article-title":"The evaluation of radiolabeled prostate-specific membrane antigen positron emission tomography\/computed tomography for initial staging in intermediate-risk prostate cancer patients: a retrospective multicenter analysis","volume":"14","author":"Evangelista","year":"2024","journal-title":"Diagnostics (Basel)."},{"key":"2025121109350928000_53.Supplement_1.132S.40","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268167"},{"key":"2025121109350928000_53.Supplement_1.132S.41","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/cancers16050939","article-title":"The current landscape of prostate-specific membrane antigen imaging biomarkers for aggressive prostate cancer","volume":"16","author":"Al Saffar","year":"2024","journal-title":"Cancers (Basel)."},{"key":"2025121109350928000_53.Supplement_1.132S.42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12967-022-03846-1","article-title":"Gene\u2019s expression underpinning the divergent predictive value of [18F]F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study","volume":"21","author":"Bauckneht","year":"2023","journal-title":"J Transl Med."},{"key":"2025121109350928000_53.Supplement_1.132S.43","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00259-019-04372-x","article-title":"Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics","volume":"46","author":"Sollini","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025121109350928000_53.Supplement_1.132S.44","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.178673"},{"key":"2025121109350928000_53.Supplement_1.132S.45","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3348\/kjr.2024.0439","article-title":"Description of FDG and prostate-specific membrane antigen PET\/CT findings in Korean patients with advanced metastatic castration-resistant prostate cancer","volume":"25","author":"Na","year":"2024","journal-title":"Korean J Radiol."},{"key":"2025121109350928000_53.Supplement_1.132S.46","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2214\/AJR.13.11673","article-title":"PET\/CT in the management of thyroid cancers","volume":"202","author":"Marcus","year":"2014","journal-title":"AJR."}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.125.271082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T17:35:39Z","timestamp":1765474539000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.125.271082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":46,"journal-issue":{"issue":"Supplement 1","published-online":{"date-parts":[[2025,12,4]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.2967\/jnmt.125.271082"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.125.271082","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}